Imlifidase Utilization in Glanzmann Thrombasthenia With Anti‐GPIIb/IIIa and Anti‐HLA Alloimmunization and Severe Platelet Refractoriness Following Hematopoietic Stem Cell Transplant

Documenti analoghi

• Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single‐center case series
  di: Ajibike Lapite, et al.
  Pubblicazione: (2024)
• Anti‐Tumor Activity of Paclitaxel‐Containing Regimens in Recurrent/Refractory Wilms Tumor
  di: Alissa Groisser, et al.
  Pubblicazione: (2025)
• Gemcitabine, Docetaxel, Melphalan, Carboplatin as Part of Sequential Cycles of High‐Dose Chemotherapy With Autologous Hematopoietic Stem‐Cell Rescue for Multiply Relapsed/Refractory Pediatric Germ Cell Tumors
  di: Maria Frost, et al.
  Pubblicazione: (2026)
• Increasing Access to Pediatric Allogeneic Hematopoietic Stem Cell Transplantation in South Africa
  di: Candice Laverne Hendricks, et al.
  Pubblicazione: (2026)
• Procedural Sedation outside the Operating Room in Pediatric Hematopoietic Stem Cell Transplant Patients
  di: Heather Xiao, et al.
  Pubblicazione: (2026)